Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
Work
Year: 2007
Type: article
Abstract: Human papillomavirus types 16 (HPV-16) and 18 (HPV-18) cause approximately 70% of cervical cancers worldwide. A phase 3 trial was conducted to evaluate a quadrivalent vaccine against HPV types 6, 11, ... more
Source: New England Journal of Medicine
Institutions University of Copenhagen, University of Helsinki, Finnish Institute for Health and Welfare, Centre International de Recherche sur le Cancer, Icelandic Cancer Society +16 more
Cites: 35
Cited by: 2,014
Related to: 10
FWCI: 143.4
Citation percentile (by year/subfield): 100
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze